Arm Holdings is a stock, not an ETF, and it carries unusually wide analyst coverage with equally wide opinions. Across recent, individually verifiable price targets following the company's November 2026 earnings, the calculated mean lands near $275. Individual post-earnings marks include $326 (Evercore ISI), $330 (Mizuho), $325 (Barclays), $300 (RBC Capital), $270 (UBS and Piper Sandler), $255 (Wells Fargo), $250 (TD Cowen and Rosenblatt), $245 (JPMorgan), and $212 (Morgan Stanley). Aggregator estimates independently cluster in a similar zone, with S&P Global's poll of roughly 43 analysts showing an average near $273 and a full range of about $125 to $500.
The spread is telling. Bulls argue the data-center and AI opportunity justifies premium multiples, while cautious voices emphasize a handset-driven royalty slowdown. Morgan Stanley's $212 target, the lowest among recent marks, sits only modestly above the current price, whereas Mizuho's $330 reflects a far more aggressive view of Arm's silicon strategy. This dispersion means the $275 figure is a statistical midpoint, not a consensus forecast or a guarantee. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
After reporting fiscal second-quarter results, ARM traded near $174.62, down sharply from its 52-week high of $452.70 and still well above its 52-week low of $100.02. Reaching $275 would require a gain of roughly 57%, a very large move even for a volatile semiconductor name.
The path would likely depend on two re-accelerations. First, royalty growth, which slowed to about 8% in the latest quarter with management guiding "low single digits" for the December quarter, would need to recover as smartphone demand stabilizes. Second, the company's new Arm AGI CPU would need to begin contributing measurable revenue, validating the premium multiple. In the most recent quarter, revenue rose 27% to $1.44 billion and adjusted EPS reached $0.52, beating guidance, but the royalty shortfall overshadowed the beat.
Arm's strongest verified tailwinds are structural. License and other revenue jumped 50% to $773 million, reflecting strong demand for its architecture. Data-center royalties doubled year over year, and Arm-based processors now power more than half of major cloud-service deployments, a share management expects to exceed 60% by the end of 2026. The Arm AGI CPU, its first silicon product with Meta as a lead partner, carries a roughly $2 billion revenue target across fiscal 2027 and 2028 and a longer-term $15 billion ambition by fiscal 2031. Valuation has also cooled: the stock's forward P/E ratio has fallen below its three-year average, which could make further gains easier if growth resumes.
The principal obstacle is royalty deceleration. Smartphone chips accounted for roughly 43% of fiscal 2026 royalty revenue, and higher memory prices have pressured handset volumes, with peer Qualcomm reporting a 26% decline in handset revenue. Arm still trades at a demanding valuation of roughly 76 times forward earnings and around 200 times trailing earnings, leaving little room for error. An unresolved legal dispute with Qualcomm over royalty payments, dependence on majority owner SoftBank for a meaningful share of licensing revenue, and broader sector volatility tied to data-center restrictions and interest-rate expectations all add risk. Any of these could compress the multiple faster than fundamentals can justify.
Arm's market structure reflects a steep multi-month decline from its June peak. The $200 round-number level and the band from roughly $212 to $250, where several cautious analyst targets and prior breakdown zones sit, represent the first meaningful resistance on any recovery toward $275. On the downside, the $160-to-$170 zone, which the stock tested after earnings, is a near-term support area, with the 52-week low near $100 acting as the deeper floor. The stock remains in a clear long-term downtrend from its high, meaning a move to $275 would require first reclaiming multiple lower levels.
Analyst price targets typically reflect a research horizon of about 12 months, though individual firms apply different assumptions about royalty recovery and AGI CPU revenue. Investors focused on the $275 question should watch Nvidia's mid-November earnings for commentary on its Arm-based Vera CPU, Arm's early-2026 report for any reacceleration in royalties, AGI CPU production and margin disclosures, and any ruling in the Qualcomm dispute. Analyst revisions after each print will signal whether the mean target is drifting toward the bulls or the bears.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, track existing positions, and spot emerging trends more efficiently than manual screening. For a name as volatile as Arm, automated signal monitoring can help filter short-term noise from genuine directional shifts. I find these signals helpful when reviewing names like this one alongside my own analysis.
The $275 target is a calculated average of recent analyst marks, not a forecast, and reaching it would require a roughly 57% advance from current levels—an outcome that hinges on royalty growth recovering and the Arm AGI CPU ramping on schedule. The bull case rests on durable data-center momentum and a cooling valuation, while the bear case points to a still-expensive multiple and a soft smartphone cycle. With targets spread from $212 to $330, and the broader analyst range from $125 to $500, investor disagreement remains extreme. The next royalty print and AGI CPU milestones will be the clearest signals of whether the path toward $275 is opening or closing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +5.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARM advanced for three days, in 182 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
ARM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARM as a result. In 35 of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for ARM turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In 22 of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
ARM moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ARM crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for ARM entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. ARM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARM's P/B Ratio (21.610) is very high in comparison to the industry average of (5.443). ARM has a moderately high P/E Ratio (178.184) as compared to the industry average of (15.640). Projected Growth (PEG Ratio) (2.327) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (50.761) is also within normal values, averaging (46.468).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors